首页> 外文期刊>Pharmacy >Polypharmacy in African American Adults: A National Epidemiological Study
【24h】

Polypharmacy in African American Adults: A National Epidemiological Study

机译:非洲裔美国成年人中的多元药房:国家流行病学研究

获取原文
           

摘要

Background: Despite the association between polypharmacy and undesired health outcomes being well established, very little is known about epidemiology of polypharmacy in the African American community. We are not aware of any nationally representative studies that have described the socioeconomic, behavioral, and health determinants of polypharmacy among African Americans. Aims: We aimed to investigate the socioeconomic and health correlates of polypharmacy in a national sample of African American adults in the US. Methods: The National Survey of American Life (NSAL, 2003–2004) included 3,570 African American adults. Gender, age, socioeconomic status (SES; education attainment, poverty index, and marital status), access to the healthcare system (health insurance and having a usual source of care), and health (self-rated health [SRH], chronic medical disease, and psychiatric disorders) in addition to polypharmacy (5 + medications) as well as hyper-polypharmacy (10 + medications) were measured. Logistic regressions were applied for statistical analysis. Results: that About 9% and 1% of all African American adults had polypharmacy and hyper-polypharmacy, respectively. Overall, higher age, higher SES (education and poverty index), and worse health (poor SRH, more chronic medical disease, and psychiatric disorders) were associated with polypharmacy and hyper-polypharmacy. Individuals with insurance and those with a routine place for healthcare also had higher odds of polypharmacy and hyper-polypharmacy. Conclusions: Given the health risks associated with polypharmacy, there is a need for systemic evaluation of medication use in older African Americans with multiple chronic conditions. Such policies may prevent medication errors and harmful drug interactions, however, they require effective strategies that are tailored to African Americans.
机译:背景:尽管多元药与不良健康结果之间的关联得到了很好的确立,但非洲裔美国人社区对多元药的流行病学知之甚少。我们尚无任何国家级代表性研究描述非裔美国人中多药店的社会经济,行为和健康决定因素。目的:我们旨在调查美国非裔美国成年人的全国样本中多药店的社会经济和健康相关性。方法:美国国家生命调查(NSAL,2003–2004)包括3,570名非洲裔美国成年人。性别,年龄,社会经济状况(SES;受教育程度,贫困指数和婚姻状况),医疗体系的使用(健康保险和通常的护理来源)以及健康状况(自评健康[SRH],长期医疗)除了多药房(5种以上药物)以及超多药房(10种以上药物)之外,还对其他疾病和精神疾病进行了测量。 Logistic回归用于统计分析。结果:在所有非洲裔美国成年人中,分别有9%和1%的人拥有综合药店和超级综合药店。总体而言,年龄较大,SES(教育和贫困指数)较高,健康状况较差(SRH较差,慢性病较多,精神病性疾病)与多药房和超级多药房有关。有保险的人和有常规医疗服务的人也拥有多药店和超级多药店的几率。结论:鉴于与多元药房相关的健康风险,有必要对患有多种慢性病的老年非洲裔美国人进行系统的药物使用评估。此类政策可以防止用药错误和有害的药物相互作用,但是,它们需要针对非裔美国人量身定制的有效策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号